Eterna Therapeutics Inc.
ERNA
Revenue
47.00k
0.000.00%
3 Months ChangeAssets
46.49M
▼-3.17M▼-6.39%
3 Months ChangeLiabilities
55.01M
▲1.94M▲3.66%
3 Months ChangeFree Cash Flow
-3.85M
▲2.20M▲36.39%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001493152-24-042902
2024-09-27
Form 8-K
ID: 0001493152-24-038532
2024-09-25
Form 8-K
ID: 0001493152-24-038129
2024-09-23
Form 8-K
ID: 0001493152-24-037815
2024-08-19
Form 8-K
ID: 0001493152-24-033119
2024-08-13
Form 10-Q
ID: 0001493152-24-031639
2024-05-14
Form 10-Q
ID: 0001140361-24-026010
2024-03-22
Form 8-K
ID: 0001140361-24-014809
2024-02-16
Form 8-K
ID: 0001140361-24-008273
2024-01-19
Form 8-K
ID: 0001140361-24-002915